More specifically, it is basically formed a consensus that CRC progression is sequential gains of mutations in Wnt signaling, RAS signaling, TGF-beta signaling, p53 signaling, PI3K-Akt signaling and MAPK signaling [29]. The gene discussed is AKT1; the disease is colorectal carcinoma.